Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nabih Maslah

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Blood Cancer Journal|January 4, 2024
Genomic and functional impact of Trp53 inactivation in JAK2V617F myeloproliferative neoplasmsPanhong Gou, Duanya Liu, Saravanan Ganesan, et al.
Pediatric Blood & Cancer|August 4, 2022
Clonal evolution in hereditary thrombocytosis with MPL T487A mutationLoic Vasseur, Remi Favier, Rathana Kim, et al.
Blood Advances|February 9, 2021
Adenylate kinase 2 expression and addiction in T-ALLNabih Maslah, Mehdi Latiri, Vahid Asnafi, et al.
Journal of Cellular and Molecular Medicine|October 21, 2024
JAK2V617F-dependent down regulation of SHP-1 expression participates in the selection of myeloproliferative neoplasm cells in the presence of TGF-βCéline Aoun, Nabih Maslah, Saravanan Ganesan, et al.
Blood Cancer Journal|October 6, 2018
Ropeginterferon alpha-2b targets JAK2V617F-positive polycythemia vera cells in vitro and in vivoEmmanuelle Verger, Juliette Soret-Dulphy, Nabih Maslah, et al.
Haematologica|June 27, 2020
Anemia and hemodilution: analysis of a single center cohort based on 2,858 red cell mass measurementsLouis Drevon, Nabih Maslah, Juliette Soret-Dulphy, et al.
The Journal of Experimental Medicine|October 19, 2020
JAK2V617F myeloproliferative neoplasm eradication by a novel interferon/arsenic therapy involves PMLTracy Dagher, Nabih Maslah, Valérie Edmond, et al.
British Journal of Haematology|August 1, 2024
Targeting the redox vulnerability of acute myeloid leukaemia cells with a combination of auranofin and vitamin CZhiliang Hei, Shujun Yang, Guifang Ouyang, et al.
Thrombosis and Haemostasis|August 14, 2018
Endothelial Cells Harbouring the JAK2V617F Mutation Display Pro-Adherent and Pro-Thrombotic FeaturesAnna Guadall, Elodie Lesteven, Gil Letort, et al.
Haematologica|September 7, 2019
Synergistic effects of PRIMA-1<sup>Met</sup> (APR-246) and 5-azacitidine in <i>TP53</i>-mutated myelodysplastic syndromes and acute myeloid leukemiaNabih Maslah, Norman Salomao, Louis Drevon, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Blood Cancer Journal|January 4, 2024
Genomic and functional impact of Trp53 inactivation in JAK2V617F myeloproliferative neoplasmsPanhong Gou, Duanya Liu, Saravanan Ganesan, et al.
Pediatric Blood & Cancer|August 4, 2022
Clonal evolution in hereditary thrombocytosis with MPL T487A mutationLoic Vasseur, Remi Favier, Rathana Kim, et al.
Blood Advances|February 9, 2021
Adenylate kinase 2 expression and addiction in T-ALLNabih Maslah, Mehdi Latiri, Vahid Asnafi, et al.
Journal of Cellular and Molecular Medicine|October 21, 2024
JAK2V617F-dependent down regulation of SHP-1 expression participates in the selection of myeloproliferative neoplasm cells in the presence of TGF-βCéline Aoun, Nabih Maslah, Saravanan Ganesan, et al.
Blood Cancer Journal|October 6, 2018
Ropeginterferon alpha-2b targets JAK2V617F-positive polycythemia vera cells in vitro and in vivoEmmanuelle Verger, Juliette Soret-Dulphy, Nabih Maslah, et al.
Haematologica|June 27, 2020
Anemia and hemodilution: analysis of a single center cohort based on 2,858 red cell mass measurementsLouis Drevon, Nabih Maslah, Juliette Soret-Dulphy, et al.
The Journal of Experimental Medicine|October 19, 2020
JAK2V617F myeloproliferative neoplasm eradication by a novel interferon/arsenic therapy involves PMLTracy Dagher, Nabih Maslah, Valérie Edmond, et al.
British Journal of Haematology|August 1, 2024
Targeting the redox vulnerability of acute myeloid leukaemia cells with a combination of auranofin and vitamin CZhiliang Hei, Shujun Yang, Guifang Ouyang, et al.
Thrombosis and Haemostasis|August 14, 2018
Endothelial Cells Harbouring the JAK2V617F Mutation Display Pro-Adherent and Pro-Thrombotic FeaturesAnna Guadall, Elodie Lesteven, Gil Letort, et al.
Haematologica|September 7, 2019
Synergistic effects of PRIMA-1<sup>Met</sup> (APR-246) and 5-azacitidine in <i>TP53</i>-mutated myelodysplastic syndromes and acute myeloid leukemiaNabih Maslah, Norman Salomao, Louis Drevon, et al.
Pageof 3